Dorman Products Q2 Results Beat Estimates; Reaffirms FY21 Guidance

In this article:

View more earnings on DORM

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement